Categories: Health

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

The transaction concerns the exercise of warrants by Thomas Bennekov, who has served as an employee-elected member of the Board of Directors of Bavarian Nordic since April 2021. The warrants were awarded to Mr. Bennekov in November 2019, prior to assuming his position on the Board.                 

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Thomas Bennekov
2. Reason for the notification
a) Position/status Employee-elected member of the Board of Directors of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code

Shares

DK0015998017

b) Nature of the transaction Exercise of warrants
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 146.60 2,596
d) Aggregated information
  • Aggregated volume
  • Price

2,596
DKK 380,573.60

e) Date of the transaction 2024-11-29
f) Place of the transaction Nasdaq Copenhagen A/S, XCSE

About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, rss@bavarian-nordic.com, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 37 / 2024

GlobeNews Wire

Recent Posts

Envu Malaysia and Universiti Sains Malaysia Forge Strategic Collaboration to Advance Sustainable Rodent Management

The partnership advances innovation in environmentally responsible pest control and supports Malaysia's oil palm industry…

6 hours ago

Best Vyvanse Alternative Over the Counter for ADHD – Natural Vyvanse Substitute – Noocube

London, May 10, 2025 (GLOBE NEWSWIRE) -- Vyvanse is a prescription medication that is used…

8 hours ago

MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss

New York, May 10, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The growing…

8 hours ago

Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025

May 10, 2025 10:00 ET  | Source: Akero Therapeutics Inc. Analysis of EFX results with…

8 hours ago

Sumatra Slim Belly Tonic Reviews: 2025 Real User Reviews Analyzed & Verified (Blue Tonic for Weight Loss)

LOS ANGELES, May 10, 2025 (GLOBE NEWSWIRE) -- Losing weight these days can feel more…

8 hours ago